Subcutaneous or intramuscular methotrexate for rheumatoid arthritis

To assess the benefits and harms of subcutaneous or intramuscular methotrexate in methotrexate-naïve adults with rheumatoid arthritis.

This is a protocol.

Health topics:

Child health > Rheumatology > Rheumatoid arthritis

Published:

15 June 2015

Authors:

Singh JA, Noorbaloochi S, Thorne C, Hazlewood GS, Suarez-Almazor ME, Tanjong Ghogomu E, Wells GA, Tugwell P

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Singh JA, Noorbaloochi S, Thorne C, Hazlewood GS, Suarez-Almazor ME, Tanjong Ghogomu E, Wells GA, Tugwell P. Subcutaneous or intramuscular methotrexate for rheumatoid arthritis. Cochrane Database of Systematic Reviews 2015, Issue 6. Art. No.: CD011730. DOI: 10.1002/14651858.CD011730